Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer (aboundsqm)
A Phase III, Randomized, Open-Label, Cross-Over, Multi-Center, Safety and Efficacy Study to Evaluate Nab-Paclitaxel (Abraxane®) as Maintenance Treatment After Induction With Nab-Paclitaxel (Abraxane®) Plus Carboplatin in Subjects With Squamous Cell Non-Small Cell Lung Cancer (NSCLC)
For more information, please visit ClinicalTrials.gov
| Patient Population | Investigational Product(s) | Phase | Status |
|---|---|---|---|
| Squamous Cell Carcinoma, Non-Small-Cell Lung | nab-Paclitaxel | III | Open and Accruing |
